Could a new shot slow Alzheimer's? major trial underway
Disease control
Not yet recruiting
This study tests a daily injection called GV1001 in 750 people aged 55-85 with moderate to severe Alzheimer's. The goal is to see if it can slow down memory and thinking decline over 24 weeks. Half the participants will get the drug, and half will get a placebo (a dummy shot), an…
Phase: PHASE3 • Sponsor: Samsung Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 11, 2026 20:50 UTC